On October 22-23rd, trade compliance experts in the life sciences and pharmaceutical industry will gather in Tyson’s Corner, Virginia for updates and best practices for importing and exporting their products while remaining compliance with CBP, BIS, and the FDA.

Featured speakers include:

• FDA Address - FDA Perspective on Importing Products in 2010
• Domenic J. Veneziano, CDR, U.S. Public Health Service, Director Division of Import Operations and Policy, Food and Drug Administration
• Keynote Address – Global Trade Compliance and the ‘Trusted Trader’ Concept”
• Marianne Rowden, President & CEO, American Association of Exporters and Importers (AAEI)
• Bradd M. Skinner, Director, C-TPAT/ Industry Partnership Programs, U.S. Customs and Border Protection
• Craig Thurber, Section Chief, U.S. Immigration & Customs Enforcement, IPR Center, U.S. Department of Homeland Security

For additional information and to register, please visit the Center for Business Intelligence, who is hosting the conference.

You can also get additional details in their press release.

Leading Medical Technologies Company Automates Trade Compliance

A leading medical technologies company ships products from over 145 locations and faced an increasingly complex supply chain spanning international borders, time zones and multiple regulatory environments. And with subsidiaries, suppliers, distributors, manufacturing facilities, carriers, brokers, and customers located all over the globe, operations were fragmented and difficult to manage.

By automating trade compliance, the company:

• Streamlined its global trade compliance process
• Minimized fines by improving licensing accuracy and efficiency
• Reduced cycle time by preventing shipment delays
• Increased visibility and availability of data between trading partners and business units
• And, reduced risk by complying with country specific regulations

Learn how this Fortune 500 company achieved these results.